Transcript Essential Medicines for Children in India Gitanjali Batmanabane MD PhD Technical Officer - Essential Medicines & Other Drugs World Health Organization Regional Office for.

Essential Medicines for Children in India
Gitanjali Batmanabane MD PhD
Technical Officer - Essential Medicines & Other Drugs
World Health Organization
Regional Office for South-East Asia
New Delhi
Geneva 30 May 2011
Overview of BMC-India
What was the problem we were trying to resolve?
How did we get started?
What processes are we using? What have we done?
What are our most important current challenges?
Where did we get stuck?
2|
Gitanjali – Geneva May 2011
What was the problem we were trying
to resolve?
 Highest number of children  Medicines widely available
dying before their fifth
 Cheap
birthday
 3 die/minute – neonatal
sepsis, diarrhoea,
pneumonia
 Too many medicines
 Quality may be an issue
 Most parts of the country
are well connected
 Health systems are in
place
 Procurement systems are
in place
3|
Gitanjali – Geneva May 2011
How did we get started?
Selection of states
 Chhattisgarh & Orissa chosen
 Poor health statistics
EMLs of the two states were analysed
 Very little children’s medicines on the list
National EML
 Mistakes, very few children’s
medicines, not current (2003)
4|
Gitanjali – Geneva May 2011
What was planned
National level activity
 Preparation of EMLc by the Indian Academy of Paediatrics
State level activities (Chhattisgarh & Orissa)
 Conduct pricing and availability
surveys
 Prepare a state EMLc
5|
Gitanjali – Geneva May 2011
What processes are we using?
Selected a professional body – expertise, many
key opinion leaders, ownership, advocacy
All basic documents were given – group of
members received background information at a
two day consultation
First draft prepared and presented – feedback
given
Revised many times over
6|
Gitanjali – Geneva May 2011
What processes are we using?
Selected a team in each state – which had
experience and previous training
Report of the comparison of the state EML with
WHO Model EMLc was given to the team
Word document template of WHO Model EMLc
given
First draft prepared and presented – feedback
given
7|
Gitanjali – Geneva May 2011
What has been done?
National level activity
Final draft stage
of the
 Preparation
of EMLc
byIAP
the EMLc
Indian Academy of Paediatrics
State level activities
 Conduct
Baselinepricing
pricingand
andavailability
availabilitysurveys
surveys done
 Prepare
a state
EMLc
State EMLs
have
been prepared
8|
Gitanjali – Geneva May 2011
What are the current challenges?
Getting permissions – time, delegation of
responsibility, signature of govt. officials
Communication – contacting PI
Budget - under or over estimate
Report writing
Quality of data, quality of the EMLc
9|
Gitanjali – Geneva May 2011
Where did we get stuck?
Preparation of EMLs – concept & principles of
selection
Professional bodies – the EML is no one’s baby
Even if EML is ready – procurement is a long way
off
Ethics clearances, financial issues (bank account)
Post survey refractory period
10 |
Gitanjali – Geneva May 2011